B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ESRRB

MOLECULAR TARGET

estrogen related receptor beta

UniProt: O95718NCBI Gene: 21032 compounds

ESRRB (estrogen related receptor beta) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ESRRB

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Genistein1.102
2Pueraria0.691

About ESRRB as a Drug Target

ESRRB (estrogen related receptor beta) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented ESRRB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ESRRB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.